Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Waiting Times in Early-Stage Non-small Cell Lung Cancer (NSCLC)

Waiting Times in Early-Stage Non-small Cell Lung Cancer (NSCLC) ORIGINAL ARTICLE Waiting Times in Early-Stage Non-small Cell Lung Cancer (NSCLC) Nathalie Saint-Jacques, MSc,* Daniel Rayson, MD, FRCP,†‡ Turki Al-Fayea, MBBS,†‡ Kiran Virik, MBBS, FRACP,†‡ Wojciech Morzycki, MD, FRCP,†‡ and Tallal Younis, FRCP†‡ Key Words: Non-small cell lung cancer, waiting times, elapsed Introduction: Wait times in cancer care continue to be an important times, adjuvant chemotherapy. clinical, social, and political issue. This study examines wait times (J Thorac Oncol. 2008;3: 865–870) along the care path from suspicious imaging study (Detection) to adjuvant chemotherapy initiation (Chemotherapy) for patients with early-stage non-small cell lung cancer (NSCLC) who undergo sur- he assessment and management of wait times, or gical resection. T‘elapsed’ times, in cancer care continues to be an impor- Methods: A retrospective chart review of patients diagnosed in 1,2 tant clinical, social, and political issue. Increasing efforts to 2005 with NSCLC who underwent curative-intent surgery in Nova define benchmarks and monitor cancer wait times and imple- Scotia, Canada was conducted to abstract dates of care events ment wait time guarantees and other related initiatives are (Detection, Surgery Consultation, Surgery, Medical Oncology [MO] 3–7 currently underway in Canada. Studies examining wait Referral, MO Consultation and Chemotherapy) and patient charac- times, which attempt http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Waiting Times in Early-Stage Non-small Cell Lung Cancer (NSCLC)

Younis, Tallal
Journal of Thoracic Oncology , Volume 3 (8) – Aug 1, 2008
Download PDF
6 pages

Loading next page...
 
/lp/wolters-kluwer-health/waiting-times-in-early-stage-non-small-cell-lung-cancer-nsclc-N0qW4T8vS0

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864
DOI
10.1097/JTO.0b013e318180210c
pmid
18670304
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Waiting Times in Early-Stage Non-small Cell Lung Cancer (NSCLC) Nathalie Saint-Jacques, MSc,* Daniel Rayson, MD, FRCP,†‡ Turki Al-Fayea, MBBS,†‡ Kiran Virik, MBBS, FRACP,†‡ Wojciech Morzycki, MD, FRCP,†‡ and Tallal Younis, FRCP†‡ Key Words: Non-small cell lung cancer, waiting times, elapsed Introduction: Wait times in cancer care continue to be an important times, adjuvant chemotherapy. clinical, social, and political issue. This study examines wait times (J Thorac Oncol. 2008;3: 865–870) along the care path from suspicious imaging study (Detection) to adjuvant chemotherapy initiation (Chemotherapy) for patients with early-stage non-small cell lung cancer (NSCLC) who undergo sur- he assessment and management of wait times, or gical resection. T‘elapsed’ times, in cancer care continues to be an impor- Methods: A retrospective chart review of patients diagnosed in 1,2 tant clinical, social, and political issue. Increasing efforts to 2005 with NSCLC who underwent curative-intent surgery in Nova define benchmarks and monitor cancer wait times and imple- Scotia, Canada was conducted to abstract dates of care events ment wait time guarantees and other related initiatives are (Detection, Surgery Consultation, Surgery, Medical Oncology [MO] 3–7 currently underway in Canada. Studies examining wait Referral, MO Consultation and Chemotherapy) and patient charac- times, which attempt

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Aug 1, 2008

References

  • Ending waiting-list mismanagement: principles and practice
    Lewis
  • Waiting for medical services in Canada: lots of heat, but little light
    Sanmartin